- Home
- KFFB vs GRML Comparison
KFFB vs GRML Comparison
Compare KFFB & GRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | KFFB | GRML |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | 5 |
| Industry | Savings Institutions | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7M | 34.9M |
| IPO Year | 2004 | 2022 |
Fundamental Metrics
Financial Performance| Metric | KFFB | GRML |
|---|---|---|
| Price | $4.90 | $0.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.2K | ★ 3.2M |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 109.52 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $15,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $33.80 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.91 | $0.21 |
| 52 Week High | $5.48 | $0.55 |
Technical Indicators
Market Signals| Indicator | KFFB | GRML |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 39.33 |
| Support Level | $4.26 | $0.21 |
| Resistance Level | N/A | $0.34 |
| Average True Range (ATR) | 0.19 | 0.04 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 51.10 | 31.34 |
Price Performance
Historical ComparisonAbout KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.
About GRML Greenland Mines Ltd. Common Stock
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.